Clinical Trial Update: Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly

View source ↗

Summary

A completed clinical trial from Karolinska Institutet evaluated the risks and benefits of anticoagulation in elderly patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Karolinska Institutet | Conditions: Anticoagulants Causing Adverse Effects in Therapeutic Use, Atrial Fibrillation | Status: COMPLETED